<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Stopping power monitoring during proton therapy by means of prompt gamma timing: first experimental results with a homogeneous phantom - Health AI Hub</title>
    <meta name="description" content="This research introduces Spatiotemporal Emission Reconstruction from Prompt-Gamma Timing (SER-PGT) as a novel method to monitor proton stopping power and range ">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Stopping power monitoring during proton therapy by means of prompt gamma timing: first experimental results with a homogeneous phantom</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.21344v1" target="_blank">2511.21344v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Julius Werner, Francesco Pennazio, Piergiorgio Cerello, Elisa Fiorina, Simona Giordanengo, Felix Mas Milian, Alessio Mereghetti, Franco Mostardi, Marco Pullia, Sahar Ranjbar, Roberto Sacchi, Anna Vignati, Magdalena Rafecas, Veronica Ferrero
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> physics.med-ph
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.21344v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.21344v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This research introduces Spatiotemporal Emission Reconstruction from Prompt-Gamma Timing (SER-PGT) as a novel method to monitor proton stopping power and range during proton therapy, aiming to reduce treatment uncertainties. The study presents the first experimental results demonstrating SER-PGT's feasibility, achieving an 8% average error in stopping power estimation and a 3 mm standard deviation in range shift detection using a homogeneous phantom. These findings highlight the potential for real-time, in-vivo dose verification in proton therapy.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This technology directly addresses critical limitations in proton therapy by providing a means for real-time, in-vivo verification of dose delivery, which is essential for optimizing treatment plans, minimizing damage to healthy tissues, and ultimately improving cancer patient outcomes.</p>
            </section>

            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Proton therapy's full potential is currently limited by uncertainties in dose distribution, primarily due to the inability to accurately measure patient tissue properties in-vivo.</li>
                    
                    <li>SER-PGT (Spatiotemporal Emission Reconstruction from Prompt-Gamma Timing) is proposed as a method to provide insights into both particle range and stopping power.</li>
                    
                    <li>The experimental setup involved a 226.9 MeV synchrotron-proton beam impinging on a homogeneous phantom at sub-clinical intensity (2 - 4 x 10^7 pps).</li>
                    
                    <li>A multi-detector system was utilized, comprising a thin, segmented Low Gain Avalanche Diode (LGAD) for proton detection and Lanthanum Bromide-based crystals for prompt gamma photon detection.</li>
                    
                    <li>The estimated stopping power profile showed an 8% ¬± 3% average error when compared to NIST PSTAR values, and a 2% ¬± 2% deviation relative to water at 100 MeV.</li>
                    
                    <li>Range assessment successfully identified a range shift caused by a 4 cm air-gap within the phantom with a 3 mm standard deviation.</li>
                    
                    <li>The study demonstrates the experimental feasibility of SER-PGT to recover both proton range and stopping power information through combined particle kinematics and prompt gamma timing measurements.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study utilized Spatiotemporal Emission Reconstruction from Prompt-Gamma Timing (SER-PGT) for simultaneous range and stopping power monitoring. Experiments were conducted using a 226.9 MeV synchrotron-proton beam at sub-clinical intensity on a homogeneous phantom. The detector setup included a thin, segmented Low Gain Avalanche Diode (LGAD) for incident proton detection and Lanthanum Bromide (LaBr3) scintillation crystals for prompt gamma photon detection. The SER-PGT method leverages particle kinematics and the precise timing of prompt gamma emissions to reconstruct the stopping power profile.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The key findings include an 8% ¬± 3% average error in the estimated stopping power profile compared to NIST PSTAR values, and a 2% ¬± 2% deviation relative to water at 100 MeV. Furthermore, the range assessment successfully identified a range shift induced by a 4 cm air-gap in the phantom with a 3 mm standard deviation, demonstrating the method's ability to accurately detect changes in proton range.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The successful demonstration of SER-PGT's feasibility for real-time monitoring of stopping power and range has significant clinical impact. It could enable more precise and adaptive proton therapy by allowing clinicians to verify dose delivery in-vivo, correct for patient motion or anatomical changes, and reduce treatment uncertainties. This precision is vital for maximizing tumor control while minimizing radiation exposure to surrounding healthy organs, potentially leading to improved therapeutic ratios and fewer treatment-related toxicities.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The experiments were conducted using a homogeneous phantom, which is a simplification compared to the complex, heterogeneous anatomy of human patients. The proton beam intensity used was sub-clinical (2 - 4 x 10^7 pps), suggesting that further validation at clinically relevant intensities will be necessary. As 'first experimental results,' the technology is still in an early stage of development.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly stated, the demonstrated feasibility strongly implies future research will focus on validating SER-PGT in more clinically relevant scenarios, including heterogeneous phantoms and eventually in-vivo studies. Efforts will also likely include optimizing the detector setup, refining reconstruction algorithms, and scaling the system for clinical beam intensities and integration into proton therapy workflows.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Radiation Oncology</span>
                    
                    <span class="tag">Medical Physics</span>
                    
                    <span class="tag">Oncology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">proton therapy</span>
                    
                    <span class="tag tag-keyword">prompt gamma timing</span>
                    
                    <span class="tag tag-keyword">stopping power</span>
                    
                    <span class="tag tag-keyword">range monitoring</span>
                    
                    <span class="tag tag-keyword">SER-PGT</span>
                    
                    <span class="tag tag-keyword">dose verification</span>
                    
                    <span class="tag tag-keyword">medical physics</span>
                    
                    <span class="tag tag-keyword">LGAD</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Proton therapy's full potential is limited by uncertainties that prevent optimal dose distribution. Monitoring techniques can reduce these uncertainties and enable adaptive treatment planning. Spatiotemporal Emission Reconstruction from Prompt-Gamma Timing (SER-PGT) is a promising method that provides insights into both particle range and stopping power, whose calculation would normally require knowledge about patient tissue properties that cannot be directly measured. We present the first experimental results using a 226.9 MeV synchrotron-proton beam impinging on a homogeneous phantom at a sub-clinical intensity (2 - 4 x 10^7 pps). SER-PGT uses data from a multi-detector setup: a thin and segmented Low Gain Avalanche Diode for proton detection and Lanthanum Bromide-based crystals for photon detection. The estimated stopping power profile showed an 8% +- 3% average error compared to NIST PSTAR values, and 2% +- 2% deviation relative to water at 100 MeV. Range assessment in a phantom with a 4 cm air-gap successfully identified the range shift with a 3 mm standard deviation. These results demonstrate the feasibility of using SER-PGT to recover both range and stopping power information through particle kinematics and PGT measurements.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>15 pages, 6 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>